Skip to main content

Table 3 Results of multivariate survival analysis

From: Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer

Characteristic Baseline model
(N=323)
Chemotherapy response-based model
(N=233)
HR 95% CI p value HR 95% CI p value
Gender (female vs male) 1.71 1.33-2.19 <0.001 1.40 1.01-1.94 0.039
KPS (70~80 vs 90~100) 0.68 0.49-0.94 0.018 0.57 0.40-0.80 0.001
Ascites   NI   1.47 1.04-2.08 0.031
Baseline WBC 1.55 1.17-2.06 0.002   NI  
Baseline N 1.35 1.03-1.78 0.032 1.56 1.14-2.13 0.005
Baseline TB 1.44 1.09-1.91 0.012   NI  
Baseline CA 19-9 1.87 1.41-2.47 <0.001 1.70 1.21-2.38 0.002
Baseline CEA   NI   1.54 1.09-2.19 0.017
Change in CA19–9 level at week 6   NI     
Decrease      Ref  
No change or increase     1.51 1.06-2.14 0.017
Change in CEA level at week 6   NI     
Decrease      Ref  
No change or increase     1.48 1.02-2.14 0.039
Initial response to chemotherapy   NI     
PD      Ref  
Non-PD     0.46 0.31-0.69 <0.001